Augmedix vs Lunit
A side-by-side look at scores, pricing and features — with RECATOOLS' ASEAN-aware verdict for each.
Augmedix
Real-time medical scribing now folded into Commure's AI suite
Visit
|
Lunit
KOSDAQ-listed Korean AI for breast and lung cancer screening
Visit
|
|
|---|---|---|
| RECATOOLS Score | 6.9 / 10 | 6.7 / 10 |
| Capability | ||
| Value for money | ||
| Ease of use | ||
| ASEAN readiness | ||
| API quality | ||
| Pricing | Enterprise | Enterprise |
| Free tier | — | — |
| Paid from | — | — |
| Has API | ✗ | ✗ |
| Open source | ✗ | ✗ |
| Free to use | ✗ | ✗ |
| Users | — | — |
| Founded | — | — |
| Maker | — | — |
| Verdict | Augmedix predates the current ambient-scribe boom — it was doing live remote medical scribing years before Abridge, Nabla and the rest turned it into a crowded category. That history shows in its "Augmedix Live" option:... |
Lunit is the most clinically validated medical-AI company to come out of Korea, and one of the few in the category with real revenue rather than just pilot deployments — Q1 2026 revenue hit 24 billion won, up nearly 25%... |
| Full review → | Full review → |
← Back to AI Directory
Comparisons cover up to 4 tools. Scores are RECATOOLS editorial assessments; verify current pricing on each vendor's site.